These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 9713879)
21. Peritonitis outcomes in patients with HIV and end-stage renal failure on peritoneal dialysis: a prospective cohort study. Ndlovu KC; Sibanda W; Assounga A BMC Nephrol; 2017 Feb; 18(1):48. PubMed ID: 28158991 [TBL] [Abstract][Full Text] [Related]
22. Relationship between uric acid and technique failure in patients on continuous ambulatory peritoneal dialysis: a long-term observational cohort study. Hsieh YP; Chang CC; Kor CT; Yang Y; Wen YK; Chiu PF; Lin CC BMJ Open; 2017 Apr; 7(4):e010816. PubMed ID: 28389481 [TBL] [Abstract][Full Text] [Related]
23. Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory peritoneal dialysis in a Mexican PD center. Sanchez AR; Madonia C; Rascon-Pacheco RA Kidney Int Suppl; 2008 Apr; (108):S76-80. PubMed ID: 18379553 [TBL] [Abstract][Full Text] [Related]
24. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin. Mars RL; Moles K; Pope K; Hargrove P Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073 [TBL] [Abstract][Full Text] [Related]
25. Prospective comparison of blood and peritoneal lymphocytes from continuous ambulatory peritoneal dialysis patients. Lewis SL; Bonner PN; Cooper CL; Holmes CJ J Clin Lab Immunol; 1992 Jan; 37(1):3-19. PubMed ID: 1339234 [TBL] [Abstract][Full Text] [Related]
26. Tissue-type plasminogen activator (tPA) and its inhibitor (PAI-1) in patients treated with continuous ambulatory peritoneal dialysis. Opatrný K; Opatrná S; Vít L; Opatrný K Am J Nephrol; 1998; 18(3):186-92. PubMed ID: 9627033 [TBL] [Abstract][Full Text] [Related]
27. Adequacy of peritoneal dialysis and nutritional status in patients on continuous ambulatory peritoneal dialysis (CAPD). Rayner B; Hollander M; Willett C S Afr Med J; 2002 Nov; 92(11):887-9. PubMed ID: 12506590 [No Abstract] [Full Text] [Related]
28. Continuous ambulatory peritoneal dialysis- a new dimension in the treatment of end-stage renal disease. Shohat J; Boner G; Rosenfeld J; Waller A; Iaina A; Eliahou HE Isr J Med Sci; 1982 Oct; 18(10):1014-8. PubMed ID: 7174268 [TBL] [Abstract][Full Text] [Related]
29. Esterase staining of human peripheral blood mononuclear cells. De Jong MC J Immunol Methods; 1979; 26(2):193-6. PubMed ID: 86588 [TBL] [Abstract][Full Text] [Related]
30. Assessment of monocyte esterase activity by flow cytophotometry. Kaplow LS; Dauber H; Lerner E J Histochem Cytochem; 1976 Jan; 24(1):363-72. PubMed ID: 1254930 [TBL] [Abstract][Full Text] [Related]
31. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia]. Stojimirović B; Grujić-Adanja G Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238 [TBL] [Abstract][Full Text] [Related]
32. Monocyte expression of tissue factor and adhesion molecules: the link with accelerated coronary artery disease in patients with chronic renal failure. Al-Saady NM; Leatham EW; Gupta S; Kwan JT; Eastwood JB; Seymour CA Heart; 1999 Feb; 81(2):134-40. PubMed ID: 9922347 [TBL] [Abstract][Full Text] [Related]
33. Successful use of continuous ambulatory peritoneal dialysis (CAPD) in the treatment of patients with renal and cardiac failure. Nakajima K; Suga T; Ishida K; Nomoto H; Tomino Y; Nomoto Y; Sakai H Tokai J Exp Clin Med; 1986 Oct; 11(4):279-83. PubMed ID: 2956730 [TBL] [Abstract][Full Text] [Related]
34. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose. Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B Nephron; 1996; 72(2):135-44. PubMed ID: 8684516 [TBL] [Abstract][Full Text] [Related]
35. Comparing automated peritoneal dialysis with continuous ambulatory peritoneal dialysis: survival and quality of life differences? Balasubramanian G; McKitty K; Fan SL Nephrol Dial Transplant; 2011 May; 26(5):1702-8. PubMed ID: 20921296 [TBL] [Abstract][Full Text] [Related]
36. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study. Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329 [TBL] [Abstract][Full Text] [Related]
38. Alleviation of sleep apnea in patients with chronic renal failure by nocturnal cycler-assisted peritoneal dialysis compared with conventional continuous ambulatory peritoneal dialysis. Tang SC; Lam B; Ku PP; Leung WS; Chu CM; Ho YW; Ip MS; Lai KN J Am Soc Nephrol; 2006 Sep; 17(9):2607-16. PubMed ID: 16885414 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of esterase activity and an undercounting of circulating monocytes in a population of production workers. Levine MS; Fox NL; Thompson B; Taylor W; Darlington AC; Van der Hoeden J; Emmett EA; Rutten W J Occup Med; 1986 Mar; 28(3):207-11. PubMed ID: 3701467 [TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore. Yang F; Lau T; Luo N Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]